Autopsy report · NCT03768310

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

“We decided to move on to another product and as a result will not be moving forward with this study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Baylor College of Medicine

Sponsor type

University, hospital or other

Conditions

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia

Interventions

CD19.CAR-multiVST for Group A; CD19.CAR-multiVST for Group B

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• REPRISE EDGE 29 mm EU Study
  “Currently not moving forward with the study” (74% match in meaning)
• Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
  “Study team is no longer moving forward with this study.” (69% match in meaning)
• Study of Body Composition Methodology in Young Children (InfantPod)
  “This study will not be conducted. A new study is replacing this one.” (67% match in meaning)
• Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast
  “Study discontinued due to lack of subject follow-up.” (66% match in meaning)
• Evaluating Return to Continence and Potency Following Radical Prostatectomy
  “The sponsor decided to not move forward with this study” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.